CN106071609A - 一种富氢钙水 - Google Patents
一种富氢钙水 Download PDFInfo
- Publication number
- CN106071609A CN106071609A CN201610546917.0A CN201610546917A CN106071609A CN 106071609 A CN106071609 A CN 106071609A CN 201610546917 A CN201610546917 A CN 201610546917A CN 106071609 A CN106071609 A CN 106071609A
- Authority
- CN
- China
- Prior art keywords
- hydrogen
- rich
- calcium
- water
- lactic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000001257 hydrogen Substances 0.000 title claims abstract description 48
- 229910052739 hydrogen Inorganic materials 0.000 title claims abstract description 48
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 title claims abstract description 47
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 title claims abstract description 39
- 229910052791 calcium Inorganic materials 0.000 title claims abstract description 39
- 239000011575 calcium Substances 0.000 title claims abstract description 39
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title claims abstract description 29
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims abstract description 34
- 241000894006 Bacteria Species 0.000 claims abstract description 17
- 239000004310 lactic acid Substances 0.000 claims abstract description 17
- 235000014655 lactic acid Nutrition 0.000 claims abstract description 17
- 239000003651 drinking water Substances 0.000 claims abstract description 16
- 235000020188 drinking water Nutrition 0.000 claims abstract description 16
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 16
- 229930014669 anthocyanidin Natural products 0.000 claims abstract description 14
- 150000001452 anthocyanidin derivatives Chemical class 0.000 claims abstract description 14
- 235000008758 anthocyanidins Nutrition 0.000 claims abstract description 14
- 150000002431 hydrogen Chemical class 0.000 claims abstract 3
- 239000000203 mixture Substances 0.000 claims description 6
- 240000007594 Oryza sativa Species 0.000 claims 1
- 235000007164 Oryza sativa Nutrition 0.000 claims 1
- 235000009566 rice Nutrition 0.000 claims 1
- 230000036541 health Effects 0.000 abstract description 8
- 238000004519 manufacturing process Methods 0.000 abstract description 4
- 235000008935 nutritious Nutrition 0.000 abstract description 2
- 229960005069 calcium Drugs 0.000 description 27
- 239000000047 product Substances 0.000 description 11
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 6
- 239000011777 magnesium Substances 0.000 description 6
- 229910052749 magnesium Inorganic materials 0.000 description 6
- 229940091250 magnesium supplement Drugs 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 239000002994 raw material Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 235000016709 nutrition Nutrition 0.000 description 4
- 230000035764 nutrition Effects 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 235000005979 Citrus limon Nutrition 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000003064 anti-oxidating effect Effects 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000006041 probiotic Substances 0.000 description 2
- 235000018291 probiotics Nutrition 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- PBWPWIZUYLTJNF-UHFFFAOYSA-N 2-aminoacetic acid;calcium Chemical compound [Ca].NCC(O)=O PBWPWIZUYLTJNF-UHFFFAOYSA-N 0.000 description 1
- GMHHOEMTCPPZJT-UHFFFAOYSA-N 2-aminoacetic acid;magnesium Chemical compound [Mg].NCC(O)=O GMHHOEMTCPPZJT-UHFFFAOYSA-N 0.000 description 1
- 244000248349 Citrus limon Species 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- JPIJQSOTBSSVTP-GBXIJSLDSA-N D-threonic acid Chemical compound OC[C@@H](O)[C@H](O)C(O)=O JPIJQSOTBSSVTP-GBXIJSLDSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- 229910000861 Mg alloy Inorganic materials 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 235000001465 calcium Nutrition 0.000 description 1
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical group [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 description 1
- 239000001354 calcium citrate Substances 0.000 description 1
- 239000004227 calcium gluconate Substances 0.000 description 1
- 229960004494 calcium gluconate Drugs 0.000 description 1
- 235000013927 calcium gluconate Nutrition 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- ZFXVRMSLJDYJCH-UHFFFAOYSA-N calcium magnesium Chemical compound [Mg].[Ca] ZFXVRMSLJDYJCH-UHFFFAOYSA-N 0.000 description 1
- OLOZVPHKXALCRI-UHFFFAOYSA-L calcium malate Chemical compound [Ca+2].[O-]C(=O)C(O)CC([O-])=O OLOZVPHKXALCRI-UHFFFAOYSA-L 0.000 description 1
- 239000001362 calcium malate Substances 0.000 description 1
- 229940016114 calcium malate Drugs 0.000 description 1
- 235000011038 calcium malates Nutrition 0.000 description 1
- NEEHYRZPVYRGPP-UHFFFAOYSA-L calcium;2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Ca+2].OCC(O)C(O)C(O)C(O)C([O-])=O.OCC(O)C(O)C(O)C(O)C([O-])=O NEEHYRZPVYRGPP-UHFFFAOYSA-L 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 235000019700 dicalcium phosphate Nutrition 0.000 description 1
- MHJAJDCZWVHCPF-UHFFFAOYSA-L dimagnesium phosphate Chemical compound [Mg+2].OP([O-])([O-])=O MHJAJDCZWVHCPF-UHFFFAOYSA-L 0.000 description 1
- 229910000395 dimagnesium phosphate Inorganic materials 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000004880 explosion Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 235000001055 magnesium Nutrition 0.000 description 1
- 229960003035 magnesium gluconate Drugs 0.000 description 1
- 239000001755 magnesium gluconate Substances 0.000 description 1
- 235000015778 magnesium gluconate Nutrition 0.000 description 1
- JFQQIWNDAXACSR-UHFFFAOYSA-L magnesium malate Chemical compound [Mg+2].[O-]C(=O)C(O)CC([O-])=O JFQQIWNDAXACSR-UHFFFAOYSA-L 0.000 description 1
- IAKLPCRFBAZVRW-XRDLMGPZSA-L magnesium;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoate;hydrate Chemical compound O.[Mg+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O IAKLPCRFBAZVRW-XRDLMGPZSA-L 0.000 description 1
- YVJOHOWNFPQSPP-PZXRSRGQSA-L magnesium;(2s,3r)-2,3,4-trihydroxybutanoate Chemical compound [Mg+2].OC[C@@H](O)[C@H](O)C([O-])=O.OC[C@@H](O)[C@H](O)C([O-])=O YVJOHOWNFPQSPP-PZXRSRGQSA-L 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- VIKNJXKGJWUCNN-XGXHKTLJSA-N norethisterone Chemical compound O=C1CC[C@@H]2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 VIKNJXKGJWUCNN-XGXHKTLJSA-N 0.000 description 1
- 230000000505 pernicious effect Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- ANRHNWWPFJCPAZ-UHFFFAOYSA-M thionine Chemical compound [Cl-].C1=CC(N)=CC2=[S+]C3=CC(N)=CC=C3N=C21 ANRHNWWPFJCPAZ-UHFFFAOYSA-M 0.000 description 1
- 235000013337 tricalcium citrate Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Non-Alcoholic Beverages (AREA)
Abstract
本发明公开了一种富氢钙水，属于饮用水领域，通过在富氢水中添加纳米螯合钙、花青素、小肽、乳酸菌，使产品的口感更好，营养丰富、具有更广的保健功能；该富氢钙水的生产方法简单，具有广阔的市场前景。
Description
技术领域
本发明涉及饮用水领域，具体涉及是一种富氢钙水及其制备方法。
背景技术
《中国水网》杂志指出：“全世界80%以上疾病和33%的死亡与受污染的饮用水有关”，在人体组织中，水分就占了70%，水质好坏对人体健康关系极大。氢分子能够中和体内恶性氧自由基，氢分子对于氧自由基引起的各种疾病具有良好的预防和治疗作用，利用氢分子的氧化还原作用还可以使人体增强抗氧化能力，减缓衰老速度，但由于氢气具有易燃易爆性，由呼吸道摄入氢气在使用上存在一定局限性，目前比较理想的方法是将氢气溶解于水中，制成富氢水，使其可以通过饮用途径来摄入氢气，增加了氢气应用的途径，提高了安全性。随着市场消费需求的多样化，保健意识的增强，消费者在考虑单纯解渴、避暑的同时，越来越注重产品的健康元素，使用产品后假如能带来身体上的健康，将更受欢迎，所以饮用水在未来发展中，将从单一解渴、避暑逐渐向健康、营养、美容等转变，富氢水饮料有望成为饮料市场的新宠和主流发展趋势。
目前，对于富氢水的研究多为制备方法，如中国专利:申请号：201410166247.0“一种富氢水的制备工艺”、申请号201410047486.4“一种富氢水生产方法”等，这些专利均公开了富氢水的制备方法，但制得的产品口味单一、营养、保健功能单一；又如中国专利：申请号2012100662980.9“一种钙镁富氢水添加剂及其制备方法”，该专利的添加剂包含制氢剂和pH 调节剂 ；所述制氢剂为钙单质、镁单质、钙镁单质组合或钙镁合金，钙选自柠檬酸钙、柠檬酸镁、葡萄糖酸钙、葡萄糖酸镁、苹果酸钙、苹果酸镁、氨基乙酸钙、氨基乙酸镁、赖氨酸钙、赖氨酸镁、苏糖酸钙、苏糖酸镁、磷酸氢钙、磷酸氢镁中的一种或多种，制得的富氢水中有钙、镁。但通过检索发现，没有在富氢水中添加纳米螯合钙、花青素、有益菌等原料，使产品的口感、营养、功能更丰富的研究。
发明内容
针对现有技术的不足，本发明的目的是提供一种富氢钙水及其制备方法，通过在富氢水中添加纳米螯合钙、花青素、小肽、有益菌，使产品的口感更好，营养丰富、具有更广的保健功能。
一种富氢钙水，由富氢饮用水、纳米螯合钙、花青素、小肽、乳酸菌组成，各组份的组成如下：富氢饮用水200-500份、纳米螯合钙0.1-0.3份、花青素0.5-2份、小肽0.1-0.3份、乳酸菌0.1-0.3份。
优选地，如上所述的一种富氢钙水，由富氢饮用水350份、纳米螯合钙0.2份、花青素1份、小肽0.2份、乳酸菌0.2份组成。
优选地，如上所述的一种富氢钙水，其中乳酸菌为过夜培养的，浓度为1.5×108～5.0×109cfu/mL。
本发明与现有技术相比，具有如下的优点：
1、在富氢水中添加花青素：花青素具有极强的抗氧化作用，可以抵御自由基对人体的损伤，预防诸如关节炎、癌症、心脏病等多种疾病，提高产品的抗氧化功能10倍以上。
2、在富氢水中添加纳米螯合钙：纳米螯合钙的人体吸收率高达95%以上，是目前已知的补钙剂中吸收率最高的，除纳米螯合钙的生物利用率高外，更重要的是，进一步的研究证实纳米螯合钙对肾、肺无钙沉积，对人体绝对安全。
3、添加小肽、乳酸菌：小肽因其结构简单，分子量小，不饱和，所以能够通过细胞膜的渗透以原形直接进入细胞内，而不需要再次消化，也不需要耗费能量，因此小分子肽的吸收、转化和利用，都是高效、完全、彻底的，同时还添加了对人体的肠道有益处，乳酸菌在人体肠道中建立了良好的微生态，使人体对小肽等营养物质、有益元素的吸收更充分。
本发明在富氢水中添加纳米螯合钙、花青素、小肽等原料，使得产品抗氧化能力提高、产品的功能更广阔，产品中的营养也更丰富，人体对各种营养物质、有益元素的吸收更充分，因此，该产品具有更广阔的市场前景。
具体实施方式
为能清楚说明本发明方案的技术特点，下面结合具体实施例，对本发明进行阐述。但是本发明的保护范围并不限于这些实施例。凡是不背离本发明构思的改变或等同替代均包括在本发明的保护范围之内。
实施例1
取富氢饮用水200克、将纳米螯合钙100毫克、花青素0.5克、小肽100毫克、乳酸菌100毫克加入富氢饮用水中，各原料混合均匀、灌装即可，其中乳酸菌过夜培养，其浓度为1.5×108cfu/mL。
实施例2
取富氢饮用水500克、将纳米螯合钙300毫克、花青素2克、小肽300毫克、乳酸菌300毫克加入富氢饮用水中，各原料混合均匀、灌装即可，其中乳酸菌过夜培养，其浓度为1.0×109cfu/mL。
实施例3
取富氢饮用水350克、将纳米螯合钙200毫克、花青素1克、小肽200毫克、乳酸菌200毫克加入富氢饮用水中，各原料混合均匀、灌装即可，其中乳酸菌过夜培养，其浓度为2.0×109cfu/mL。
Claims (3)
1.一种富氢钙水，其特征在于：该富氢钙水由富氢饮用水、纳米螯合钙、花青素、小肽、乳酸菌组成，各组份的组成如下：富氢饮用水200-500份、纳米螯合钙0.1-0.3份、花青素0.5-2份、小肽0.1-0.3份、乳酸菌0.1-0.3份。
2.如权利要求1所述的一种富氢钙水，其特征在于：该富氢钙水由富氢饮用水350份、纳米螯合钙0.2份、花青素1份、小肽0.2份、乳酸菌0.2份组成。
3.如权利要求1或2所述的一种富氢钙水，其特征在于：乳酸菌浓度为1.5×108～5.0×109cfu/mL。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610546917.0A CN106071609A (zh) | 2016-07-13 | 2016-07-13 | 一种富氢钙水 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610546917.0A CN106071609A (zh) | 2016-07-13 | 2016-07-13 | 一种富氢钙水 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106071609A true CN106071609A (zh) | 2016-11-09 |
Family
ID=57221268
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610546917.0A Pending CN106071609A (zh) | 2016-07-13 | 2016-07-13 | 一种富氢钙水 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106071609A (zh) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108271977A (zh) * | 2018-01-26 | 2018-07-13 | 上海科洋众创空间管理中心（有限合伙） | 抗氧化花青素饮液及其制备方法 |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH1014535A (ja) * | 1996-07-05 | 1998-01-20 | Karunaa:Kk | 飲食品用カルシウム剤 |
| TW200932687A (en) * | 2007-11-22 | 2009-08-01 | Bio Res Inc | Method for making drinking water containing hydrogen |
| CN101623033A (zh) * | 2008-07-07 | 2010-01-13 | 内蒙古伊利实业集团股份有限公司 | 含蜂蜜和蜂花粉的液态乳制品及其生产方法 |
| CN102557227A (zh) * | 2012-03-12 | 2012-07-11 | 彭振业 | 一种钙镁富氢水添加剂及其制备方法 |
| KR20130055757A (ko) * | 2011-11-21 | 2013-05-29 | 이규재 | 수소와 칼슘이 풍부한 알칼리 환원수를 제조하는 방법 및 이의 알칼리 환원수 |
| CN105030952A (zh) * | 2015-07-07 | 2015-11-11 | 上海交通大学医学院附属第三人民医院 | 一种用于预防尿结石的组合物 |
| CN105105256A (zh) * | 2015-07-22 | 2015-12-02 | 邓绍祥 | 富氢保健饮料及其制备方法 |
| KR101612221B1 (ko) * | 2015-03-12 | 2016-04-12 | 지병욱 | 항ㆍ살균 기능을 갖는 수소발생 미네랄 스틱 |
-
2016
- 2016-07-13 CN CN201610546917.0A patent/CN106071609A/zh active Pending
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH1014535A (ja) * | 1996-07-05 | 1998-01-20 | Karunaa:Kk | 飲食品用カルシウム剤 |
| TW200932687A (en) * | 2007-11-22 | 2009-08-01 | Bio Res Inc | Method for making drinking water containing hydrogen |
| CN101623033A (zh) * | 2008-07-07 | 2010-01-13 | 内蒙古伊利实业集团股份有限公司 | 含蜂蜜和蜂花粉的液态乳制品及其生产方法 |
| KR20130055757A (ko) * | 2011-11-21 | 2013-05-29 | 이규재 | 수소와 칼슘이 풍부한 알칼리 환원수를 제조하는 방법 및 이의 알칼리 환원수 |
| CN102557227A (zh) * | 2012-03-12 | 2012-07-11 | 彭振业 | 一种钙镁富氢水添加剂及其制备方法 |
| KR101612221B1 (ko) * | 2015-03-12 | 2016-04-12 | 지병욱 | 항ㆍ살균 기능을 갖는 수소발생 미네랄 스틱 |
| CN105030952A (zh) * | 2015-07-07 | 2015-11-11 | 上海交通大学医学院附属第三人民医院 | 一种用于预防尿结石的组合物 |
| CN105105256A (zh) * | 2015-07-22 | 2015-12-02 | 邓绍祥 | 富氢保健饮料及其制备方法 |
Non-Patent Citations (1)
| Title |
|---|
| 邓伟民等: "《谨记隐形杀手——骨质疏松》", 31 October 2010, 军事医学科学出版社 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108271977A (zh) * | 2018-01-26 | 2018-07-13 | 上海科洋众创空间管理中心（有限合伙） | 抗氧化花青素饮液及其制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2021236518B2 (en) | A highly concentrated seawater mineral extract and uses thereof | |
| CN107668314A (zh) | 一种工业化生产豌豆活性肽及制备方法 | |
| CN103876142B (zh) | 一种具有美容瘦身功效的超微粉咀嚼片及其制备方法 | |
| EP1307408A1 (en) | Additive method of standardized drinks and potable water production | |
| CN102860512B (zh) | 一种乌鸡肽铁螯合物生物补铁剂的制备方法 | |
| WO2023213325A1 (zh) | 一种超高纯度二十八烷醇-黄酮复合去氘水组合协同精制的高能饮料及其制备方法 | |
| CN101747222B (zh) | 甘氨酸螯合牡蛎钙水相合成方法及高钙酱油的制备 | |
| CN106071609A (zh) | 一种富氢钙水 | |
| EP2125700A1 (en) | L-carnitine calcium fumarate, preparation method and application for the same | |
| CN1951236A (zh) | 燕窝酸饮料及其制备方法 | |
| CN114134190A (zh) | 一种玉米蛋白活性肽载运钙离子纳米螯合物的制备方法 | |
| CN102018158A (zh) | 一种芦荟果酱 | |
| CN102754714A (zh) | 西木耳茶及其制备方法 | |
| CN106360626A (zh) | 一种儿童型有机营养低钠盐的制备方法 | |
| CN107759309A (zh) | 一种栽培辣木茶的纳米碳有机富硒肥料 | |
| CN107699602A (zh) | 一种由阿胶制备富有机亚铁阿胶肽的工业生产方法和应用 | |
| CN102948733B (zh) | 一种特殊食用生命营养液的生产方法和配方 | |
| CN106261237A (zh) | 一种沙棘汁饮料及其生产工艺 | |
| CN107279865A (zh) | 一种玛咖牡蛎食疗产品及其制备方法 | |
| CN105211416A (zh) | 一种菊花茶及其制备方法 | |
| CN107828843A (zh) | 一种由蚌肉制备的富有机微量元素蚌肉肽的工业生产方法和应用 | |
| KR20110113431A (ko) | 무가당 홍삼과립차 제조방법 | |
| CN109511755A (zh) | 一种保健茶 | |
| CN1692783A (zh) | 阿胶奶及其制备工艺 | |
| CN105211422A (zh) | 一种金银花茶及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20161109 |
|
| RJ01 | Rejection of invention patent application after publication |